文献速递衰弱、肌少症与跌倒老年综合评估

衰弱与COVID-19患者结局的关联:动态综述与荟萃分析

Association of frailty with outcomes in individuals with COVID-19: A living review and meta-analysis.
PubMed 文献 · J Am Geriatr Soc · 2021-06-05

该动态系统综述与荟萃分析纳入52项研究、共118373例COVID-19成年患者,评估衰弱与结局的关联。使用临床衰弱量表(CFS)评估的衰弱在混杂因素调整后仍与死亡率显著相关(OR 1.79,95%CI 1.49-2.14;HR 1.87,95%CI 1.33-2.61),未调整时与谵妄风险升高及ICU入住几率降低相关。作者认为衰弱评估有助于预后判断和个体化照护规划。

要点

  • CFS评估的衰弱与COVID-19患者调整后死亡率升高显著相关(OR 1.79,95%CI 1.49-2.14)。
  • 未调整分析中,CFS衰弱与谵妄风险升高及ICU入住几率降低相关。
  • 患者报告结局、费用和体验结局极少被报告,需进一步研究。

核心结论

  • 衰弱与COVID-19患者死亡率显著增加相关,即使经过混杂因素调整。
  • 衰弱患者谵妄风险也增加。
  • 衰弱评估可能有助于指导预后和个体化照护规划,但缺乏患者报告结局数据。

研究设计与样本

  • 系统综述与荟萃分析,纳入52项报告衰弱与COVID-19结局关联的研究,共118373例COVID-19成年患者。
  • 使用Quality in Prognostic studies工具评估偏倚风险,采用随机效应模型按衰弱工具合并调整和未调整效应量。

主要发现

  • 临床衰弱量表(CFS)是最常用的衰弱评估工具,37项研究报告了死亡率。
  • 调整混杂后,CFS评估的衰弱与COVID-19阳性患者死亡率显著相关:OR 1.79(95%CI 1.49-2.14),HR 1.87(95%CI 1.33-2.61)。
  • 未调整分析中,CFS评估的衰弱与谵妄风险升高及ICU入住几率降低显著相关。
  • 使用其他衰弱评估工具的结果总体一致。
  • 患者报告、费用和体验结局极少被报告。

关键数值与推荐

  • CFS评估的衰弱与调整后死亡率相关:OR 1.79(95%CI 1.49-2.14),HR 1.87(95%CI 1.33-2.61)。
  • 未调整分析中,CFS评估的衰弱与谵妄风险升高及ICU入住几率降低相关。

临床怎么用

  • 对COVID-19老年患者可考虑使用CFS进行衰弱评估以辅助预后判断和个体化照护规划。
  • 衰弱评估可能有助于识别死亡和谵妄高风险患者,但需结合患者报告结局综合评估。

局限性

  • 患者报告、费用和体验结局极少被报告,无法全面评估对老年人重要的结局。
  • 研究间衰弱评估工具异质性较大,多数研究使用CFS,其他工具结果总体一致但需谨慎解读。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Frailty leaves older adults vulnerable to adverse health outcomes. Frailty assessment is recommended by multiple COVID-19 guidelines to inform care and resource allocation. We aimed to identify, describe, and synthesize studies reporting the association of frailty with outcomes (informed by the Institute for Healthcare Improvement's Triple Aim [health, resource use, and experience]) in individuals with COVID-19. DESIGN: Systematic review and meta-analysis. SETTING: Studies reporting associations between frailty and outcomes in the setting of COVID-19 diagnosis. PARTICIPANTS: Adults with COVID-19. MEASUREMENTS: Following review of titles, abstracts and full text, we included 52 studies that contained 118,373 participants with COVID-19. Risk of bias was assessed using the Quality in Prognostic studies tool. Our primary outcome was mortality, secondary outcomes included delirium, intensive care unit admission, need for ventilation and discharge location. Where appropriate, random-effects meta-analysis was used to pool adjusted and unadjusted effect measures by frailty instrument. RESULTS: The Clinical Frailty Scale (CFS) was the most used frailty instrument. Mortality was reported in 37 studies. After confounder adjustment, frailty identified using the CFS was significantly associated with mortality in COVID-19 positive patients (odds ratio 1.79, 95% confidence interval [CI] 1.49-2.14; hazard ratio 1.87, 95% CI 1.33-2.61). On an unadjusted basis, frailty identified using the CFS was significantly associated with increased odds of delirium and reduced odds of intensive care unit admission. Results were generally consistent using other frailty instruments. Patient-reported, cost and experience outcomes were rarely reported. CONCLUSION: Frailty is associated with a substantial increase in mortality risk in COVID-19 patients, even after adjustment. Delirium risk is also increased. Frailty assessment may help to guide prognosis and individualized care planning, but data relating frailty status to patient-reported outcomes are urgently needed to provide a more comprehensive overview of outcomes relevant to older adults.

来源:J Am Geriatr Soc,查看原文。版权归原作者所有。

引用

  1. Dumitrascu F, Branje KE, Hladkowicz ES, et al. Association of frailty with outcomes in individuals with COVID-19: A living review and meta-analysis. J Am Geriatr Soc. 2021. PMID: 34048599. doi:10.1111/jgs.17299

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。